Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avenue Growth Lending Fund III is a venture debt fund managed by Avenue Capital Group that provides senior secured loans to high-growth companies. The fund specifically targets the life sciences, technology, and clean energy sectors, offering non-dilutive capital to companies backed by top-tier venture capital firms. It focuses on providing flexible financing solutions to help companies reach their next milestones, such as clinical trial completion or commercial expansion. Within the healthcare sector, the fund invests in a diverse range of sub-sectors including biotechnology, medical devices, and healthcare IT. By leveraging the global platform of Avenue Capital Group, the fund provides strategic value beyond just capital to its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avenue Growth Lending Fund III.